Sequoia Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.43M | Sell |
14,810
-1,000
| -6% | -$480K | 0.04% | 270 |
|
|
2026
Q1 | $7.77M | Buy |
15,810
+466
| +3% | +$253K | 0.04% | 241 |
|
|
2025
Q4 | $8.89M | Buy |
15,344
+466
| +3% | +$264K | 0.05% | 216 |
|
|
2025
Q3 | $7.22M | Buy |
14,878
+247
| +2% | +$115K | 0.04% | 242 |
|
|
2025
Q2 | $5.93M | Sell |
14,631
-85,560
| -85% | -$35.8M | 0.04% | 257 |
|
|
2025
Q1 | $49.9M | Buy |
100,191
+5,620
| +6% | +$3.04M | 0.38% | 58 |
|
|
2024
Q4 | $49.2M | Buy |
94,571
+5,303
| +6% | +$2.92M | 0.47% | 43 |
|
|
2024
Q3 | $55.2M | Buy |
89,268
+4,879
| +6% | +$2.89M | 0.59% | 35 |
|
|
2024
Q2 | $46.7M | Buy |
84,389
+4,758
| +6% | +$2.73M | 0.56% | 37 |
|
|
2024
Q1 | $46.3M | Buy |
79,631
+34,843
| +78% | +$19.6M | 0.58% | 35 |
|
|
2023
Q4 | $23.8M | Buy |
44,788
+38,503
| +613% | +$18.6M | 0.29% | 71 |
|
|
2023
Q3 | $3.18M | Buy |
6,285
+453
| +8% | +$241K | 0.06% | 187 |
|
|
2023
Q2 | $3.04M | Sell |
5,832
-520
| -8% | -$281K | 0.05% | 195 |
|
|
2023
Q1 | $3.66M | Sell |
6,352
-16,120
| -72% | -$9.09M | 0.08% | 160 |
|
|
2022
Q4 | $12.4M | Buy |
22,472
+4,399
| +24% | +$2.33M | 0.3% | 63 |
|
|
2022
Q3 | $9.17M | Buy |
18,073
+300
| +2% | +$168K | 0.29% | 71 |
|
|
2022
Q2 | $9.66M | Buy |
17,773
+14,519
| +446% | +$7.99M | 0.27% | 72 |
|
|
2022
Q1 | $1.92M | Buy |
3,254
+867
| +36% | +$498K | 0.05% | 196 |
|
|
2021
Q4 | $1.59M | Buy |
2,387
+1,703
| +249% | +$1.06M | 0.04% | 201 |
|
|
2021
Q3 | $391K | Sell |
684
-2,809
| -80% | -$1.54M | 0.04% | 175 |
|
|
2021
Q2 | $1.76M | Buy |
3,493
+1,161
| +50% | +$548K | 0.06% | 163 |
|
|
2021
Q1 | $1.06M | Sell |
2,332
-534
| -19% | -$255K | 0.04% | 183 |
|
|
2020
Q4 | $1.33M | Buy |
2,866
+51
| +2% | +$23.9K | 0.06% | 157 |
|
|
2020
Q3 | $1.24M | Buy |
2,815
+67
| +2% | +$27.7K | 0.07% | 148 |
|
|
2020
Q2 | $996K | Buy |
2,748
+135
| +5% | +$45.3K | 0.06% | 146 |
|
|
2020
Q1 | $741K | Buy |
2,613
+41
| +2% | +$12.9K | 0.05% | 146 |
|
|
2019
Q4 | $836K | Buy |
2,572
+481
| +23% | +$146K | 0.05% | 156 |
|
|
2019
Q3 | $609K | Sell |
2,091
-329
| -14% | -$94.2K | 0.04% | 175 |
|
|
2019
Q2 | $711K | Buy |
2,420
+650
| +37% | +$179K | 0.05% | 154 |
|
|
2019
Q1 | $484K | Sell |
1,770
-405
| -19% | -$101K | 0.04% | 190 |
|
|
2018
Q4 | $487K | Hold |
2,175
| – | – | 0.06% | 147 |
|
|
2018
Q3 | $531K | Hold |
2,175
| – | – | 0.05% | 155 |
|
|
2018
Q2 | $451K | Hold |
2,175
| – | – | 0.05% | 170 |
|
|
2018
Q1 | $449K | Buy |
2,175
+885
| +69% | +$186K | 0.05% | 168 |
|
|
2017
Q4 | $245K | Buy |
1,290
+96
| +8% | +$18.4K | 0.03% | 253 |
|
|
2017
Q3 | $226K | Buy |
1,194
+19
| +2% | +$3.44K | 0.03% | 251 |
|
|
2017
Q2 | $205K | Buy |
+1,175
| New | +$197K | 0.03% | 266 |
|
Other funds holding TMO
Sequoia Financial Advisors's TMO Position: Q2 2026 in Review
Sequoia Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, selling an estimated $480K and leaving 14,810 shares worth $7.43M. The position accounts for 0.04% of the portfolio, ranked #270.
Sequoia Financial Advisors first reported a position in TMO in Q2 2017 and has held it in 37 quarters since. The position peaked at $55.2M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Sequoia Financial Advisors held 14,810 shares of Thermo Fisher Scientific worth $7.43M as of Q2 2026.
- Sequoia Financial Advisors sold 1,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $480K.
- Thermo Fisher Scientific made up 0.04% of Sequoia Financial Advisors's portfolio in Q2 2026, its #270 holding.
- Sequoia Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 37 quarters since.
- Sequoia Financial Advisors's Thermo Fisher Scientific position peaked at $55.2M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.